Ami Wilkinson
Impact in
- Infectious Diseases top 5%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- Genetics top 5%
- Genetic Associations and Epidemiology
Papers in
- Genetics 7
- Genetic Associations and Epidemiology 6
- Inflammatory Bowel Disease 1
-
- COVID-19 Clinical Research Studies 3
- SARS-CoV-2 and COVID-19 Research 1
- Journals
- Nature (4 papers)JAMA Network Open (1 paper)The Lancet Neurology (1 paper)Human Genetics and Genomics Advances (1 paper)JAMA Neurology (1 paper)
- Partner nations
- United KingdomSwitzerland
In The Last Decade
Ami Wilkinson
9 papers receiving 1.1k citations
Ami Wilkinson's Hit Papers
Peers
Comparison fields: 5 of 70
- Infectious Diseases 554
- Genetics 503
- Neurology 93
- Immunology 95
- Internal Medicine 9
Countries citing papers authored by Ami Wilkinson
This map shows the geographic impact of Ami Wilkinson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ami Wilkinson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ami Wilkinson more than expected).
Fields of papers citing papers by Ami Wilkinson
This network shows the impact of papers produced by Ami Wilkinson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ami Wilkinson. The network helps show where Ami Wilkinson may publish in the future.
No co-authors to show.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Mapping the human genetic architecture of COVID-19 Hit paper breakdown → | 2021 | 656 |
| 2 | Whole-genome sequencing reveals host factors underlying critical COVID-19 Hit paper breakdown → | 2022 | 233 |
| 3 | GWAS and meta-analysis identifies 49 genetic variants underlying critical COVID-19 Hit paper breakdown → | 2023 | 125 |
| 4 | 2021 | 79 | |
| 5 | 2023 | 60 | |
| 6 | 2024 | 19 | |
| 7 | 2022 | 8 | |
| 8 | 2024 | 8 | |
| 9 | 2025 | 1 | |
| 10 | 2021 | 0 | |
| 11 | 2026 | 0 |
About Ami Wilkinson
Ami Wilkinson is a scholar working on Genetics, Infectious Diseases, Cardiology and Cardiovascular Medicine, Nuclear Energy and Engineering and Waste Management and Disposal, having authored 11 papers that have together received 1.2k indexed citations. Recurring topics across this work include Genetic Associations and Epidemiology (6 papers), COVID-19 Clinical Research Studies (3 papers), Atrial Fibrillation Management and Outcomes (3 papers), SARS-CoV-2 and COVID-19 Research (1 paper) and Inflammatory Bowel Disease (1 paper). The work is most often cited by research in Infectious Diseases (554 citations), Genetics (503 citations), Neurology (93 citations), Immunology (95 citations) and Internal Medicine (9 citations). Ami Wilkinson has collaborated with scholars based in United Kingdom and Switzerland. Their work appears in journals such as Nature, JAMA Network Open, The Lancet Neurology, Human Genetics and Genomics Advances and JAMA Neurology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.